Predictors of dropout in the German disease management program for type 2 diabetes by Fullerton, Birgit et al.
RESEARCH ARTICLE Open Access
Predictors of dropout in the German disease
management program for type 2 diabetes
Birgit Fullerton
1*, Antje Erler
1, Boris Pöhlmann
2 and Ferdinand M Gerlach
1
Abstract
Background: To improve and assess the effectiveness of disease management programs (DMPs), it is critical to
understand how many people drop out of disease management programs and why.
Methods: We used routine data provided by a statutory health insurance fund from the regions North Rhine,
North Wurttemberg and Hesse. As part of the German DMP for type 2 diabetes, the insurance fund received
regular documentation of all members participating in the program. We followed 10,989 patients who enrolled in
the DMP between July 2004 and December 2005 until the end of 2007 to study how many patients dropped out
of the program. Dropout was defined based on the discontinuation of program documentation on a particular
patient, excluding situations in which the patient died or left the insurance fund. Predictors of dropout, assessed at
the time of program enrolment, were explored using logistic regression analysis.
Results: 5.5% of the patients dropped out of the disease management program within the observation period.
Predictors of dropout at the time of enrolment were: region; retirement status; the number of secondary diseases;
presence of a disabling secondary disease; doctor’s recommendations to stop smoking or to seek nutritional
counselling; and the completion and outcome of the routine foot and eye exams. Different trends of dropout were
observed among retired and employed patients: retired patients of old age, who possibly drop out of the program
due to other health care priorities and employed people of younger age who have not yet developed many
secondary diseases, but were recommended to change their lifestyle.
Conclusions: Overall, dropout rates for the German disease management programs for type 2 diabetes were low
compared to other studies. Factors assessed at the time of program enrolment were predictive of later dropout
and should be further studied to provide information for future program improvements.
Background
In Germany, disease management programs for type 2
diabetes (DMP DM 2) were introduced on a nationwide
scale in 2003. All German statutory health insurance
(SHI) funds, which cover about 85% of the German
population [1,2], are required, by law, to offer these pro-
grams, though participation is voluntary for doctors and
patients. Over the years, DMP participation has been
increasing continuously. To date, there are about 3.4
million patients enrolled in the DMP DM 2 in Germany,
which are approximately 40% to 60% of all diabetic
patients in Germany [3,4]. Key components of German
DMPs are evidence-based treatment guidelines, patient
training, the regular documentation of disease develop-
ment and treatment goals, as well as provider feedback.
Usually, general practitioners (GPs) act as coordinating
physicians: they enrol patients into the program, orga-
nize patient training, and negotiate individual treatment
goals with patients [5,6].
T h ee v a l u a t i o no fG e r m a nD M P si sal e g a lr e q u i r e -
ment: it is carried out according to a pre-determined
design based on data from routine documentation forms
that doctors have to submit at regular intervals for every
enrolled patient [7,8]. This official evaluation program
has been criticized for its methods, such as the lack of a
control group, which makes it difficult to assess effec-
tiveness of the programs [9,10].
Recently, several studies showed improvements in
care, such as adherence to treatment guidelines and the
completion of regular routine exams, as well as patient
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ity [5,11-14] (but also see [15]).
However, in many of the studies potential biases are
insufficiently addressed. One aspect that has been
ignored in the official evaluation program, as well as in
some of the recent studies, is the rate of attrition
[5,8,14]. Understanding the mechanisms of patients’
dropout from DMPs is important to evaluate potential
bias due to attrition in studies that look at the effective-
ness of DMPs [16,17]. Furthermore, improved knowl-
edge of how many and which kind of patients are likely
to drop out of the DMP is important to decide whether
and how the design of these programs could be
improved to avoid losing patients who could potentially
benefit from disease management.
Therefore, in this study we wanted to specifically focus
on dropout from DMPs. We aimed to investigate, firstly,
h o wm a n yp e o p l ew h oi n i t i a l l ye n r o l l e di naD M Pl e f t
the program again at a later time. Secondly, to better
understand the underlying reasons, we looked at which
variables assessed at the time of enrolment were predic-
tive of later dropout.
Methods
Data
To investigate the research question we used anon-
ymized routine DMP data from the Techniker Kranken-
k a s s e( T K ) ,al a r g eG e r m a nS H If u n d ,f r o mt h er e g i o n s
Hesse, North Rhine, and North Wurttemberg from the
years 2004 to 2007. Doctors who participate in a DMP
are required to fill in a documentation form for every
enrolled patient every three or six months depending on
the severity of the disease. There are separate forms for
enrolment of a patient and follow-up documentation.
The official evaluation institute receives the full docu-
mentation data, which includes some clinical data, such
as blood pressure, HbA1c, and medication. SHI funds,
however, only receive a reduced dataset. Our analysis is
based on this reduced dataset, which includes informa-
tion on: diabetes duration; whether the patient has dia-
betes-specific symptoms; use of diabetes medication; the
diagnosis of secondary diseases (hypertension; stroke;
lipid disorder; coronary hear disease (CHD); nephropa-
thy; retinopathy; neuropathy; peripheral artery disease
(PAD); blindness; myocardial infarction; amputation;
diabetic foot; dialysis); the foot status; the number of
hypoglycaemic events; the number of hospital admis-
sions due to hyperglycaemia within the last twelve
months; whether the patients has participated in or was
recommended to take part in training; whether the
patient has received an annual ophthalmological exam;
whether the patient was given recommendations to stop
smoking or seek nutritional advice; and therapy goals
such as to alter or hold the HbA1c or blood pressure.
Data from the DMP documentation were linked with
the routine claims data from the insurance fund to
obtain further information on patient age, gender,
region, insurance status and whether the patient had
died or left the insurance fund during the observation
period.
Study design
We used a study design of a retrospective cohort study.
Our study population consisted of all patients who
enrolled in the DMP for the first time between July 1
st
2004 and December 31
st 2005. We did not include any
enrolments before July 2004, because different docu-
mentation forms were used. Patients who died or left
the insurance fund before the end of 2007 were
excluded from the analysis. Patients were followed-up
until the end of 2007. The outcome of interest was
whether patients would drop out of the DMP. Dropout
was defined as a patient having no DMP documentation
(no follow-up documentation but also no new enrol-
ment) for at least all of the last year of follow-up (2007).
For the remainder of the article, patients with missing
DMP documentation in 2007 are referred to as the
dropout group; the other patients are referred to as the
DMP group.
Data analysis
All baseline data at the time of DMP enrolment was
analyzed descriptively by calculating absolute and rela-
tive frequencies for categorical variables and means and
standard deviations for continuous variables. The chance
of dropout was modelled using logistic regression. For
the regression models, secondary diseases were summar-
ized in the variables ‘two or more secondary diseases’
and ‘disabling secondary disease’, whereby stroke, blind-
ness, amputation and dialysis were considered disabling
secondary diseases. All variables were first analyzed
u s i n gu n i v a r i a t em o d e l s .A d d i t i o n a l l yam u l t i v a r i a t e
logistic model was built using backward elimination and
forward selection. Finally, we also added the variables
age and gender to the final multivariate model indepen-
dent of whether they showed any association with the
outcome. Model performance was evaluated using the
Hosmer-Lemeshow test. Patterns of health care utiliza-
tion have been observed to be different for younger
employed and for retired elderly patients: Retired elderly
patients highly value a close and continuous relationship
to their GP [18]), while younger, employed patients have
shown to be more critical towards their primary health
care provider and less adherent to his recommendations
[19]. Therefore, we also carried out the analysis strati-
fied by insurance status.
Patients with missing values in any of the variables
were excluded from the analysis. The frequencies of
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the two groups of patients.
Results
Overall, 11,933 patients enrolled in the DMP Diabetes
mellitus type 2 between 1.7.2004 and 31.12.2005. 304
patients died and 443 patients left the insurance fund
before the end of 2007 - they were excluded from the
analysis. Of the remaining 11,186 patients a further 197
cases were excluded due to missing data (see figure 1).
From the final group of 10,989 patients, 5.5% (604)
dropped out of the DMP within the observation period.
Missing data
For 197 patients we found missing values in six of the
baseline variables (see table 1). Overall, the amount of
missing data was low and the distribution of missing
values was similar in the dropout group compared to
the DMP group. Therefore, we accepted the assumption
that values were missing completely at random as plau-
sible and only performed a complete case analysis.
Baseline
The baseline data from the time of DMP enrolment are
shown in table 2. The mean age of the study population
was 63.2 (SD = 10.0) years and 67.5% were male. This
high representation of men in our study population is
likely due to the fact that the TK traditionally was a SHI
fund for people with technical professions. On average,
patients had lived with diabetes for 6.1 years and the
majority was taking some form of diabetes medication
(68.5%). 17.6% had not yet developed any secondary dis-
eases, but 19.5% suffered from more than one secondary
disease. 20.3% of the patients had already participated in
a diabetes training program before enrolment in the
DMP; only 0.2% had participated in a hypertension
training program. 35.2% of the patients were recom-
mended by their doctor to seek nutritional counselling
and 11.1% were recommended to stop smoking. For
49.6% of the patients, the treatment goals included low-
ering the HbA1c and 30.8% of the patients aimed to
lower their blood pressure. The annual eye exam - for
which the DMP guidelines demand that the patient
should be referred to a specialist - had been completed
in 39.1% of the cases and was already scheduled in
another 37.1%.
Logistic regression models
The results of the univariate logistic regression models
are shown in table 3. These variables were then used for
building a multivariate logistic model. Two methods of
variable selection, forward selection and backward elimi-
nation, resulted in the same model, which included the
variables region, insurance status, number of secondary
diseases, presence of a disabling secondary disease,
recommendation to stop smoking, recommendation to
seek nutritional counselling, performance of the annual
eye exam, and examination of the foot status. The mul-
tivariate odds ratios shown in table 4 are based on a
logistic model that in addition to these variables also
includes the variables age and gender, even though
these variables did not show a strong association with
dropout. The results suggest that the probability of
dropout from the DMP is lower for patients from North
Rhine or Hesse compared to patients from North Wurt-
temberg. Patients who were already retired at the time
of enrolment into the DMP were also less likely to leave
the DMP compared to full insurance members, who are
usually employed. The presence of several secondary
diseases at the time of enrolment was generally asso-
ciated with a decreased probability of dropout, unless
these secondary diseases were of a disabling nature, in
which case the probability of dropout was increased.
Dropout was also associated with treatment goals set at
the time of enrolment. Patients who were recommended
to stop smoking or to seek nutritional counseling were
at an increased risk of dropout. Whether the DMP
guidelines-recommended regular exams were carried out
also seemed to influence the probability of later dropout.
People who had already visited an ophthalmologist for
the recommended yearly eye exam were less likely to
leave the DMP compared to patients for whom the
11,933 patients enrolled 
in the DMP between
1.7.2004 and 31.12.2005
10,989 patients used 
for analysis
304 patients died
before the end 
of 2007
443 patients left the
insurance fund before 
the end of 2007
197 patients 
excluded due to 
missing values
604 patients dropped 
out of the DMP
10,385 patients 
continued the DMP
Figure 1 Flow chart of data processing.
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guidelines that doctors examine the feet of diabetic
patients. If the exam had not been carried out at enrol-
ment or if the foot status was abnormal compared to a
normal result, we found the probability of dropout to be
increased.
T a b l e5s h o w st h eo d d sr a t i o so ft h es a m el o g i s t i c
regression model as described above, but stratified
according to insurance status. Since the number of peo-
ple with insurance status ‘family member’ is low, we
only show the results for members and retired persons.
While age showed no significant association with drop-
out in the overall model, it shows opposite effects in the
two different membership subgroups: for retired patients
higher age is associated with a higher probability of
dropout, while for people who are still employed, older
people are less likely to drop out of the DMP. Regarding
the presence of secondary diseases, both groups show
similar trends. While the recommendation to stop
smoking seems to have more effect within the ‘member’
group, it seems that the effects regarding routine eye
and foot examinations mainly apply to the group of
retired patients.
Discussion
In this study we identified a number of factors measured
a tt h et i m eo fp a t i e n te n r o l m e n ti n t ot h eD M PD M2
that were associated with later dropout from the pro-
gram. We found that patients from North Wurttemberg
tended to dropout from the DMP more frequently com-
pared to patients from other regions. This result might
reflect the different levels of acceptance of DMPs in dif-
ferent regions in Germany [20]. In the region North
Rhine for example, similarly structured programs for the
management of diabetes had existed long before the
current DMPs were introduced [21]. Here, the accep-
tance of disease management programs was high and
implementation quick. Most patients who had partici-
pated in the structured diabetes programs were then
enrolled in the DMP DM 2. On the contrary, in North
Wurttemberg, resistance against the introduction of
DMPs from doctors was high, which might have also
affected continuity in patients’ DMP participation. Drop-
out was further associated with insurance status,
number of secondary diseases, presence of a disabling
secondary disease, treatment goals requiring behavioral/
lifestyle changes (such as the recommendation to stop
smoking or seek nutritional counselling) and the com-
pletion of regular exams required by the DMP guide-
lines. Based on an additional analysis stratified
according to insurance status (see table 5), we could
observe different trends for the group of patients who
were still working and those who were retired. Among
t h ee m p l o y e d ,t h o s ew h ow e r ey o u n g e r ,h e a l t h i e ra n d
recommended by their doctor to change their lifestyle
were especially at risk of later dropping out of the DMP.
Among the retired however, predictors of dropout were
older age, the presence of a disabling secondary disease,
an abnormal foot status or routine exams not being car-
ried out. These could possibly reflect two very different
reasons for dropout. First, for younger people who are
still fairly healthy and pre-occupied with their working
life, DMPs might not be perceived as beneficial, but
rather the requests to make changes to their lifestyle
might be perceived as an inconvenience. Second, retired
people of older age might also be at higher risk of drop-
out, since other health-related issues might obtain
higher priority; patients might be close to the end of
their life, spend more time in hospital or move to long-
term care. The observation that not carrying out the
required routine exam(s) was also associated with drop-
out in this group could possibly also be a reflection of
the doctor’s decision that due to other circumstances in
the life of the patient, these exams might not be neces-
sary anymore. Further research would be needed to
explore these trends of dropout in more detail.
Overall, we found the percentage of patients dropping
out of the DMP DM 2 to be low (5.5%) in our study.
However, we only followed patients over a short time
period and our ability to measure dropout accurately
might have been limited. Dropout rates in international
studies on disease management vary widely. In a recent
meta-analysis including 41 randomized controlled trials
on disease management interventions with varying dura-
tions from 1.5 to 48 months, dropout rates ranged
between 1.1 and 39.8% (mean = 14.0%) [22]. The results
from this meta-analysis refer to dropouts of clinical
trials, which might not reflect real-world conditions and
Table 1 Frequency of missing values across variables
DMP (n = 10571) Dropout (n = 615) total (n = 11186)
Insurance status 109 (1.0%) 5 (0.8%) 114 (1.0%)
Blood pressure treatment goal 1 (0.0%) 0 (0.0%) 1 (0.0%)
Foot status 1 (0.0%) 0 (0.0%) 1 (0.0%)
Diabetes duration 74 (0.7%) 6 (1.0%) 80 (0.7%)
Hospital admissions due to hyperglycaemia 2 (0.0%) 0 (0.0%) 2 (0.0%)
Gender 109 (1.0%) 5 (0.8%) 114 (1.0%)
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DMP (n = 10385) Dropout (n = 604) Overall (n = 10989)
Age - Mean (SD) 63.3 (9.8) 62.6 (12.5) 63.2 (10.0)
Diabetes duration in years - Mean (SD) 6.1 (6.7) 6.0 (6.7) 6.1 (6.7)
Gender - n (%) male 6998 (67.4) 414 (68.5) 7412 (67.5)
Region - n (%)
Hesse 3042 (29.3) 169 (28.0) 3211 (29.2)
North Wurttemberg 1175 (11.3) 92 (15.2) 1267 (11.5)
North Rhine 6168 (59.4) 343 (56.8) 6511 (59.3)
Insurance status - n (%)
member 3815 (36.7) 261 (43.2) 4076 (37.1)
retired 5960 (57.4) 310 (51.3) 6270 (57.1)
family 610 (5.9) 33 (5.5) 643 (5.9)
Hypertension - n (%) 7147 (68.8) 391 (64.7) 7538 (68.6)
Stroke - n(%) 427 (4.1) 7.6 (5.8) 462 (4.2)
Lipid disorder - (%) 4377 (42.2) 37.6 (37.6) 4604 (41.9)
CHD - n (%) 1578 (15.2) 84 (13.9) 1662 (15.1)
Nephropathy - n (%) 468 (4.5) 22 (3.6) 490 (4.5)
Retinopathy - n (%) 393 (3.8) 28 (4.6) 421 (3.8)
Neuropathy - n (%) 986 (9.5) 65 (10.8) 1051 (9.6)
PAD - n (%) 575 (5.5) 33 (5.5) 608 (5.5)
Blindness - n (%) 17 (0.2) 4 (0.7) 21 (0.2)
Myocardial infarction - n (%) 661 (6.4) 32 (5.3) 693 (6.3)
Amputation - n (%) 41 (0.4) 4 (0.7) 45 (0.4)
Diabetic foot - n (%) 128 (1.2) 12 (2.0) 140 (1.3)
Dialysis - n (%) 20 (0.2) 1 (0.2) 21 (0.2)
No secondary diseases - n (%) 1817 (17.5) 112 (18.5) 1929 (17.6)
Two or more secondary diseases - n (%) 2034 (19.6) 105 (17.4) 2139 (19.5)
Disabling secondary disease
1 - n (%) 487 (4.7) 41 (6.8) 528 (4.8)
Diabetes symptoms - n (%) 3019 (29.1) 193 (32.0) 3212 (29.2)
Diabetes medication - n (%) 7115 (68.5) 410 (67.9) 7525 (68.5)
Severe hypoglycaemic episodes within the last 12 months - n (%) 121 (1.2) 12 (2.0) 133 (1.2)
Hospital admissions due to hyperglycaemia - n (%) 66 (0.6) 5 (0.8) 71 (0.7)
Foot status - n (%)
normal 9244 (89.0) 513 (84.9) 9757 (88.8)
abnormal 423 (4.1) 36 (6.0) 459 (4.2)
not assessed 718 (6.9) 55 (9.1) 773 (7.0)
Diabetes training received - n (%) 2129 (20.5) 105 (17.4) 2234 (20.3)
Diabetes training recommended - n (%) 3257 (31.4) 217 (35.9) 3474 (31.6)
Hypertension training received - n (%) 26 (0.3) 0 (0.0) 26 (0.2)
Hypertension training recommended - n 866 (8.3) 45 (7.5) 911 (8.3)
(%)
Nutritional counseling recommended - n (%) 3628 (34.9) 243 (40.2) 3871 (35.2)
Recommendation to stop tobacco use - n (%) 1128 (10.9) 87 (14.4) 1215 (11.1)
HbA1c treatment goal - n (%)
hold 5229 (50.4) 286 (47.4) 5515 (50.2)
lower 5136 (49.5) 316 (52.3) 5452 (49.6)
raise 20 (0.2) 2 (0.3) 22 (0.2)
Blood pressure treatment goal - n (%)
hold 7193 (69.3) 415 (68.7) 7608 (69.2)
lower 3192 (30.7) 189 (31.3) 3381 (30.8)
Annual eye exam - n (%)
done 4102 (39.5) 199 (33.0) 4301 (39.1)
scheduled 3831 (36.9) 244 (40.4) 4075 (37.1)
not done 2452 (23.6) 161 (26.7) 2613 (23.8)
SD: standard deviation, CHD: coronary heart disease, PAD: peripheral artery disease, All variables refer to the time of programme enrolment.
1 Stroke, amputation,
blindness and dialysis were considered disabling secondary diseases.
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OR (95%-CI)
Age
10 years difference 0.94 (0.86, 1.02)
Diabetes duration in years
5 years difference 0.99 (0.93, 1.05)
Gender
male 1
female 0.95 (0.80, 1.13)
Region
North Wurttemberg 1
North Rhine 0.71 (0.56, 0.90)
Hesse 0.71 (0.55, 0.92)
Insurance status
member 1
retired 0.76 (0.64, 0.90)
family 0.79 (0.55, 1.15)
2 or more secondary diseases
<2 1
≥ 2 0.86 (0.70, 1.07)
Disabling secondary disease
1
no 1
yes 1.48 (1.06, 2.06)
Diabetes symptoms
no 1
yes 1.15 (0.96, 1.37)
Diabetes medication
no 1
yes 0.97 (0.82, 1.16)
Severe hypoglycaemic episodes within the last 12
months
no 1
yes 1.72 (0.95, 3.13)
Hospital admissions due to hyperglycaemia
no 1
yes 1.31 (0.52, 3.25)
Foot status
normal 1
abnormal 1.53 (1.08, 2.18)
not assessed 1.38 (1.04, 1.84)
Diabetes training received
no 1
yes 0.82 (0.66, 1.01)
Diabetes training recommended
no 1
yes 1.23 (1.03, 1.46)
Hypertension training recommended
no 1
yes 0.89 (0.65, 1.21)
Nutritional counseling recommended
no 1
yes 1.25 (1.06, 1.48)
Recommendation to stop tobacco use
no 1
Table 3 Univariate logistic models of dropout (Continued)
yes 1.38 (1.09, 1.75)
HbA1c treatment goal
hold 1
lower 1.13 (0.95, 1.33)
raise 1.83 (0.43, 7.86)
Blood pressure treatment goal - n (%)
hold 1
lower 1.03 (0.86, 1.23)
Annual eye exam - n (%)
done 1
not done 1.35 (1.09, 1.68)
scheduled 1.31 (1.08, 1.59)
All variables refer to the time of programme enrolment.
1 Stroke, amputation,
blindness and dialysis were considered disabling secondary diseases.
Table 4 Multivariate logistic model of dropout
OR (95% CI) p-value
Age
10 years difference 1.05 (0.95; 1.18) 0.3476
Gender
male 1
female 1.01 (0.83;1.22) 0.9607
Region
North Wurttemberg 1
North Rhine 0.70 (0.55; 0.89) 0.0032
Hesse 0.71 (0.54; 0.92) 0.0099
Insurance status
member 1
retired 0.74 (0.59; 0.92) 0.0075
family 0.80 (0.53; 1.18) 0.2575
Number of secondary diseases
<2 1
≥ 2 0.77 (0.61; 0.98) 0.0351
Disabling secondary disease
1
no 1
yes 1.79 (1.26; 2.56) 0.0013
Recommendation to stop smoking
no 1
yes 1.32 (1.03; 1.68) 0.0262
Recommendation to seek nutritional
counseling
no 1
yes 1.22 (1.03; 1.45) 0.0222
Ophthalmological exam
done 1
not done 1.32 (1.06; 1.64) 0.0131
scheduled 1.26 (1.04; 1.53) 0.0197
Foot status
normal 1
abnormal 1.66 (1.16; 2.37) 0.0059
not assessed 1.35 (1.01; 1.81) 0.0437
All variables refer to the time of programme enrolment.
1 Stroke, amputation,
blindness and dialysis were considered disabling secondary diseases.
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ease management programs outside of study conditions.
However, similarly varied results can be found in studies
looking at attrition rates from diabetes education ser-
vices, either at physician-led diabetic clinics or diabetes
education centres usually lead by diabetes educators. In
studies carried out in Britain, the United States, Canada,
Ireland, and Japan, dropout rates ranged from 4 to 57%
per year [23,24]. Due to the diversity of programs as
well as variations in assessing attrition, comparison
between studies is difficult. Enrolment in the German
DMPs is voluntary. Furthermore, inclusion criteria for
the German DMPs are the willingness and ability of the
patient to actively participate in the programme and an
expected benefit for the patient in terms of an improve-
ment in quality of life and life expectation. The GP as
coordinating physician decides about a patient’s suitabil-
ity for the programme. Therefore DMP participants are
likely to be a selected group in that they might be more
motivated and able to reach their treatment goals, take
responsibility to self-managet h e i rc h r o n i cd i s e a s e ,a n d
are adherent to treatment recommendations. Patients
with low motivation or ability to follow recommenda-
tions to improve the management of their disease would
be enrolled in the DMP less frequently because of a lack
of potential benefit. This could explain why the overall
rate of drop-out was low in our study.
Regarding predictors of dropout, our results are con-
sistent with the results from international studies. As in
our primary analysis, most studies did not find a rela-
tionship between attrition and gender, age or diabetes
duration [24]. If we stratified for retirement status, how-
ever, we found an association between attrition and age.
As in our results, retirement status itself was signifi-
cantly related to dropout in other studies [24,25]. Also,
in qualitative studies, in which patients were asked why
they discontinued program participation, conflicts with
work was a reason frequently given [23]. Other reasons
given were low perceived concern for the disease, not
considering attendance important, not feeling sick, but
Table 5 Predictors of dropout stratified by insurance status
Employed OR (95% CI) Retired OR (95% CI)
Age
10 years difference 0.82 (0.70; 0.95) 1.55 (1.30; 1.84)
Gender
male 1
female 0.91 (0.65;1.28) 1.04 (0.82; 1.32)
Region
North Wurttemberg 1
North Rhine 0.70 (0.48; 1.00) 0.69 (0.50; 0.97)
Hesse 0.57 (0.38; 0.86) 0.80 (0.55; 1.15)
Number of secondary diseases
<2 1
≥ 2 0.67 (0.43; 1.05) 0.87 (0.65; 1.16)
Disabling secondary disease
1
no 1
yes 1.88 (0.90; 3.92) 1.64 (1.08; 2.49)
Recommendation to stop smoking
no 1
yes 1.44 (1.05; 1.96) 1.21 (0.79; 1.86)
Recommendation to seek nutritional counseling 1
no 1.28 (0.99; 1.66) 1.25 (0.99; 1.60)
yes
Ophthalmological exam
done 1
not done 1.19 (0.84; 1.70) 1.46 (1.09; 1.95)
scheduled 1.39 (1.03; 1.89) 1.13 (0.86; 1.48)
Foot status
normal 1
abnormal 1.60 (0.81; 3.14) 1.75 (1.14; 2.68)
not assessed 1.03 (0.63; 1.68) 1.58 (1.08; 2.32)
All variables refer to the time of programme enrolment.
1 Stroke, amputation, blindness and dialysis were considered disabling secondary diseases
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our data we found a similar trend, as patients suffering
from a disabling secondary disease as well as patients
with fewer secondary diseases were more likely to drop-
out of the program. The association of dropout with
recommendations to stop smoking or seek nutritional
counselling has not been explicitly investigated in other
studies; however, results on smoking status and dietary
treatment in relation to the likelihood of dropout were
contradictory.
Other variables, which have been shown to be related
to patient dropout and were not addressed in our study,
were socio-economic status, patients’ perceptions, atti-
tudes and beliefs as well as variables related to the pro-
gram provider, such as physician-specific variables,
practice structure and organization [23-25].
The definition of dropout
Since it is not part of the DMP routine documentation
to record when a patient ends his or her participation in
a DMP, and since we only relied on routine data in this
study without asking patients or doctors directly, we
used a definition of dropout based on the presence or
absence of submitted DMP documentation forms. As
described above, there are two types of documentation
forms, one for enrolment in the DMP and one for fol-
low-up. We found that 40.7% of the patients had one or
more documentation of enrolment after their initial
e n t r yi n t ot h eD M P .I nt h i ss t u d yw ei g n o r e dt h e s er e -
enrolments, as we do not know whether the use of an
additional enrolment form necessarily implies that the
patient had left the DMP and then enrolled again. There
also might be other reasons for why a doctor submits a
new enrolment documentation instead of a follow-up
documentation: for example, in the DMP DM 2, until
July 2008, a new enrolment form needed to be sub-
mitted every time a patient changed to a new doctor, in
which case a new enrolment form might have been used
even though the patient never interrupted his or her
participation in the DMP. Another situation in which a
second enrolment would occur is if a patient missed
two subsequent follow-up documentation intervals, or if
the patient without plausible reason did not participate
in patient training within 12 months after it had been
recommended to him or her twice. In this situation the
p a t i e n tw o u l db er e m o v e df r o mt h eD M Pb yt h eh e a l t h
insurance, but could re-enrol at a later time. We investi-
gated the patterns of re-enrolments in more detail and
found that in 31.1% (1,561) of the cases, re-enrolment
was associated with a change to a new doctor, and in
30.8% (1,547) the patient was missing at least two docu-
mentation intervals before the time of re-enrolment,
indicating removal from the DMP and later re-enrol-
ment. In 9.1% (457) we observed both a change of
doctor and a documentation break of two or more inter-
vals preceding re-enrolment. However, for 47.2% (2,370)
of all re-enrolments, we could not identify any possible
reason for why these patients should have been re-
enrolled - they neither changed doctor nor did they
miss enough appointments to be excluded from the
DMP (see table 6). For this reason we decided not to
differentiate between enrolment and follow-up docu-
mentation forms in this study and defined dropout
solely based on the absence of any kind of submitted
DMP documentation in 2007.
We also did not take into account to what extent
patients actually participated in the program as
intended. There may have been some patients who,
although officially enrol l e d ,m i s s e dm o s to ft h e i r
appointments (since in our definition of dropout, the
number of missed appointments did not matter). In the-
ory, a patient could have enrolled in the DMP once in
2004 or 2005, and then not participate in the DMP until
2007 and would not have been considered a dropout as
long as he or she had at least one DMP documentation
form in 2007. In our data, we found that in fact 60.6%
(6,662) of all patients had at least one missing routine
documentation and 29.5% (3,240) had missed 20% or
more of the required appointments (see table 6). We
would argue that the extent to which patients actually
participate in the DMP as planned is a separate issue
from that of discontinuing participation completely and
likely would have led to different results.
Since patients ending their DMP participation is not
documented as part of the routine data collection, we
a l s od on o tk n o ww h oi n i t i a t e dad r o p o u tf r o mt h e
DMP: was it the patient’s decision to leave the program,
was it the doctor’s decision, or did program participa-
tion end due to external circumstances, such as a long
stay in rehabilitative care; in which case the insurance
fund would have ended the DMP participation
Table 6 Re-enrolments and missed appointments
Possible reasons for re-enrolment % (n)
Changed to new doctor 31.1
(1,561)
Missed previous 2 documentation intervals 30.8
(1,547)
Changed to new doctor and missed previous 2
documentation intervals
9.1 (457)
No reason identified 47.2
(2,370)
Missed documentation intervals
At least one missing documentation 60.6
(6,662)
≥ 20% of documentations missing 29.5
(3,240)
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mentation intervals.
Strengths and weaknesses of the study
To our knowledge, this study is the first that explicitly
examined dropout from DMPs in Germany. We believe
that looking at attrition should be an important aspect
of the evaluation of DMPs: firstly, because the attrition
rate can be a strong indicator of the success of the pro-
gram, secondly, because understanding which people are
likely to dropout and for which reasons can provide
valuable information for the improvement of DMPs, and
thirdly, because not taking attrition into account appro-
priately when evaluating the effectiveness of DMPs
could lead to biased results.
The main weaknesses of this study are related to the
u s eo fr o u t i n ed a t a .W ek n o wo n l yv e r yl i t t l ea b o u tt h e
validity of the data that is collected routinely as part of
DMPs. The regional data collection agencies carry out
completeness and plausibility checks, but to our knowl-
edge no one has yet carried out external validity checks
based on other data sources such as the patients’ medi-
cal records. Due to the use of routine data, we also have
little direct understanding of the reasons for why the
patient left the program. Furthermore, we were only
able to look at a limited number of variables provided in
the routine data set. However, the use of routine data
allowed us to study a large number of patients, which
would have not been feasible otherwise.
Another limitation of our study is the short duration
of the follow-up period: we only studied people who left
the DMP a short time after enrolment. A very different
group of people might remain in the DMP for a longer
period and only decide much later to discontinue their
participation. Finally, we only studied data from one
sickness fund in three regions in Germany. The level of
interest in DMPs has been shown to vary widely region-
ally and between different sickness funds [20,26,27].
Therefore, our results may not be representative for all
of Germany.
Conclusions
Overall dropout from the German disease management
program DM 2 seems to be low, but variables assessed
at the time of enrolment are predictive of future drop-
out. We could identify two trends of dropout: firstly,
retired patients of old age, who possibly drop out of the
DMP due to other health care priorities towards the end
of life and secondly, employed people of younger age
who have not yet developed many secondary diseases,
but were recommended to change their lifestyle. Both
patterns of dropout are important for the evaluation of
the effectiveness of DMPs, since they could bias the
results if not taken into account appropriately. The
second trend should be of particular interest for the
design of DMPs, since it applies to a group of patients
who could benefit the most from preventive measures
offered as part of the DMP. Further research is needed
to investigate in more detail to what extent the DMP
DM 2 can successfully include patients at earlier stages
of disease and if this may help them to take preventive
measures to avoid disease progression.
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